Related Experiment Video
Updated: Apr 28, 2026

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
IBS with constipation, functional constipation, painful and non-painful constipation: e Pluribus…Plures?
Filippo Cremonini1, Anthony Lembo2
1Southern Nevada VA Healthcare System, Las Vegas, Nevada, USA.
Distinguishing between Irritable Bowel Syndrome with constipation (IBS-C) and Chronic Constipation (CC) is challenging. Overlap in symptoms like abdominal pain suggests current criteria may need refinement for accurate diagnosis.
Area of Science:
- Gastroenterology
- Clinical diagnostics
- Functional gastrointestinal disorders
Background:
- Irritable Bowel Syndrome with constipation (IBS-C) and Chronic Constipation (CC) share overlapping symptoms, complicating clinical differentiation.
- The Rome III criteria strictly exclude CC patients with abdominal pain from IBS-C diagnosis, despite evidence of symptom overlap.
- Previous research indicates a significant percentage of CC patients exhibit abdominal pain and other IBS features.
Discussion:
- The strict exclusion criteria in Rome III may lead to misclassification of patients with constipation-predominant functional bowel disorders.
- A proposed subclassification for CC based on abdominal pain and IBS features warrants further investigation.
- Evolving diagnostic criteria necessitate a deeper understanding of the key differentiating features between IBS-C and CC.
Key Insights:
- A substantial proportion of patients diagnosed with Chronic Constipation also experience abdominal pain, a hallmark of IBS-C.
- Clinical presentation alone can be insufficient to reliably distinguish between IBS-C and CC under current Rome III guidelines.
- The presence of abdominal pain in CC patients suggests a potential need for revised diagnostic approaches.
Outlook:
- Further research is needed to validate proposed subclassifications of CC and refine diagnostic criteria for functional constipation disorders.
- Future iterations of diagnostic criteria, like the Rome criteria, should consider symptom overlap to improve diagnostic accuracy.
- Enhanced diagnostic tools and criteria will improve patient management and therapeutic strategies for IBS-C and CC.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

